Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors

被引:59
作者
Pedersen-Bjergaard, J
Andersen, MK
Johansson, B
机构
[1] Univ Copenhagen Hosp, Rigshosp, Finsen Ctr, Sect 5702,Lab Canc Genet & Cytogenet, DK-2100 Copenhagen O, Denmark
[2] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden
关键词
D O I
10.1200/JCO.1998.16.5.1897
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1897 / 1898
页数:2
相关论文
共 15 条
[1]  
ANDERSEN MK, IN PRESS HAEMATOLOGI
[2]   Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia:: Rare events related to DNA-topoisomerase II inhibitors? [J].
Dissing, M ;
Le Beau, MM ;
Pedersen-Bjergaard, J .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1890-1896
[3]   Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase .2. A report of two cases and a review of the literature [J].
Hoffmann, L ;
Moller, P ;
PedersenBjergaard, J ;
Waage, A ;
Pedersen, M ;
Hirsch, FR .
ANNALS OF ONCOLOGY, 1995, 6 (08) :781-788
[4]  
LARSON RA, 1992, BLOOD, V79, P1892
[5]  
MITELMAN F, 1998, IN PRESS CATALOG CHR
[6]  
NUCIFORA G, 1993, BLOOD, V81, P2728
[7]   TRANSLOCATION (3-21)(Q26-Q22) IN THERAPY-RELATED MYELODYSPLASIA FOLLOWING DRUGS TARGETING DNAS-TOPOISOMERASE-II COMBINED WITH ALKYLATING-AGENTS, AND IN MYELOPROLIFERATIVE DISORDERS UNDERGOING SPONTANEOUS LEUKEMIC TRANSFORMATION [J].
PEDERSENBJERGAARD, J ;
JOHANSSON, B ;
PHILIP, P .
CANCER GENETICS AND CYTOGENETICS, 1994, 76 (01) :50-55
[8]  
PEDERSENBJERGAARD J, 1991, BLOOD, V78, P1147
[9]  
PEDERSENBJERGAARD J, 1993, LEUKEMIA, V7, P1975
[10]   Chemotherapy-related and late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? [J].
PedersenBjergaard, J ;
BrondumNielsen, K ;
Karle, H ;
Johansson, B .
LEUKEMIA, 1997, 11 (09) :1571-1574